Related Experiment Video
Updated: May 26, 2026

09:01
Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
[VEGF gene expression in transfected human multipotent stromal cells].
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|December 8, 2011
Summary
Nonviral gene delivery methods like electroporation and lipofection effectively transfect adipose stromal cells. Differences in plasmid elimination and vascular endothelial growth factor (VEGF) expression were observed between cell cultures.
Area of Science:
- Cell biology
- Gene therapy
- Molecular biology
Context:
- Adipose-derived multipotent stromal cells (MSCs) are a promising source for regenerative medicine.
- Efficient and stable gene expression in MSCs is crucial for therapeutic applications.
- Nonviral transfection methods offer potential advantages over viral vectors.
Purpose:
- To investigate the dynamics of vascular endothelial growth factor (VEGF) gene expression in adipose-derived MSCs following nonviral transfection.
- To compare the efficacy of electroporation and lipofection in terms of transfection efficiency, plasmid elimination, and VEGF expression levels.
- To identify factors influencing gene expression stability and magnitude in transfected MSCs.
Summary:
- Electroporation and lipofection were employed to transfect adipose-derived MSCs with a VEGF-expressing plasmid.
- Distinct patterns of plasmid elimination were observed, categorizing cultures into fast and slow eliminators.
- Significant interculture variability in VEGF expression was detected, with a potential for 5-6 fold increase.
- No significant differences were found between electroporation and lipofection regarding transfection potency, plasmid elimination dynamics, or VEGF expression.
Impact:
- This study provides insights into the variability of gene expression following nonviral transfection of MSCs.
- Understanding plasmid elimination dynamics is essential for optimizing gene therapy strategies using MSCs.
- The findings highlight the potential for achieving substantial VEGF expression increases, relevant for angiogenic therapies.
Related Concept Videos
Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
Embryonic Stem Cells
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

